PRESS RELEASE published on 12/10/2025 at 17:45, 6 months 11 days ago Valneva annonce des résultats finaux de Phase 2 positifs sur la persistance des anticorps et l’innocuité de son vaccin contre le chikungunya IXCHIQ® chez les enfants Valneva annonce des résultats positifs de persistance des anticorps et d'innocuité de son vaccin IXCHIQ® contre le chikungunya chez les enfants. Des données confortent la sélection d'une dose complète pour une future étude clinique de Phase 3 Valneva Étude Clinique Enfants Vaccin Chikungunya
PRESS RELEASE published on 12/10/2025 at 17:45, 6 months 11 days ago Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ® Valneva reports positive final phase 2 antibody persistence and safety results for children with its Chikungunya vaccine IXCHIQ®. Twelve-month data supports full dose selection for Phase 3 trial Phase 3 Trial Valneva Vaccine Chikungunya Antibody Persistence
BRIEF published on 12/05/2025 at 18:39, 6 months 16 days ago VALNEVA: Declaration of Shares and Voting Rights Euronext Paris Voting Rights Ordinary Shares Valneva 2025
BRIEF published on 12/05/2025 at 18:39, 6 months 16 days ago VALNEVA : Déclaration d'Actions et de Droits de Vote Euronext Paris Droits De Vote Actions Ordinaires Valneva 2025
BRIEF published on 12/05/2025 at 18:39, 6 months 16 days ago Valneva Updates Share and Voting Rights as of November 2025 Stock Options Euronext Paris Voting Rights Valneva Double Voting Rights
BRIEF published on 12/05/2025 at 18:39, 6 months 16 days ago Valneva met à jour ses actions et ses droits de vote à compter de novembre 2025 Euronext Paris Options D'achat D'actions Droit De Vote Valneva Double Droit De Vote
PRESS RELEASE published on 12/05/2025 at 18:34, 6 months 16 days ago VALNEVA Déclaration d’actions et de droits de vote : 30 novembre 2025 VALNEVA déclare des actions et des droits de vote, dont un passage en droit de vote double et un exercice d'options de souscription d'actions. Informations sur le siège social et le marché réglementé Euronext Paris Déclaration Droits De Vote Actions Valneva
PRESS RELEASE published on 12/05/2025 at 18:34, 6 months 16 days ago VALNEVA Declaration of shares and voting rights: November 30, 2025 VALNEVA declares changes in shares and voting rights, including double voting rights granted on ordinary shares and transfer into bearer form Euronext Paris Voting Rights Shares Valneva Double Voting Rights
BRIEF published on 12/03/2025 at 11:03, 6 months 19 days ago Valneva SE: Promising Developments in Lyme Disease Vaccine Valneva SE Lyme Disease Vaccine Market Forecast Pfizer VLA15
BRIEF published on 12/03/2025 at 11:03, 6 months 19 days ago Valneva SE : Développements prometteurs dans le domaine du vaccin contre la maladie de Lyme Valneva SE Vaccin Contre La Maladie De Lyme Prévisions Du Marché Pfizer VLA15
Published on 06/22/2026 at 15:58, 1 hour 30 minutes ago Metallic Minerals Closes Upsized C$10.3 Million Bought Deal LIFE Private Placement
Published on 06/22/2026 at 15:30, 1 hour 58 minutes ago NanoViricides Has Shipped NV-387 Oral Gummies Drug Product for Phase II Clinical Trial to DR Congo
Published on 06/22/2026 at 15:00, 2 hours 28 minutes ago Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Published on 06/22/2026 at 14:01, 3 hours 27 minutes ago Worksport (NASDAQ:WKSP) Achieves 35% May Gross Margin, Lands Meyer Distribution, Targets $36M+ Revenue Run-Rate
Published on 06/22/2026 at 14:00, 3 hours 28 minutes ago Adcore Enters Strategic Partnership with TikTok as a Channel Sales Partner
Published on 06/22/2026 at 16:21, 1 hour 7 minutes ago Fuller, Smith & Turner PLC: Share Buyback Programme
Published on 06/22/2026 at 16:05, 1 hour 23 minutes ago ACEMATE Tennis Robot S10 Gets $600 Prime Day Discount, with Bonus Gifts
Published on 06/22/2026 at 15:33, 1 hour 54 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 06/22/2026 at 15:32, 1 hour 55 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 06/22/2026 at 08:30, 8 hours 58 minutes ago Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 8 hours 58 minutes ago Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 21 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 21 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026